Cefdinir

Product NDC: 72789-550
11-digit product format: 727890550
Labeler code: 72789
Product ID: 72789-550_4b98b00b-451b-cac7-e063-6394a90a2eb0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: CAPSULE
Route: ORAL
Labeler: PD-Rx Pharmaceuticals, Inc.
Application: ANDA065434
Marketing category: ANDA
Marketing start: 2008-01-07
Substance: CEFDINIR
Active strength: 300 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065434-001	CEFDINIR	CEFDINIR	300MG	CAPSULE / ORAL	AB		2008-01-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A065434-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065434-001	CEFDINIR	300MG	CAPSULE / ORAL	AB	2008-01-07	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065434-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065434-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065434-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065434-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065434-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065434-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065434-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065434-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065434-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065434-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065434-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065434-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065434-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065434-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065434-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065434-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065434-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065434-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065434-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065434-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065434-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065434-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065434-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065434-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065434-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065434-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065434-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065434-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065434-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065434-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065434-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065434-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065434-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065434-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065434-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065434-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065434-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065434-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065434-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065434-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Cefdinir
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFDINIR	300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
CI0FAO63WC	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
200346	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a5f028d5-ab33-491e-a385-56e79e165150	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d3e72f63-2c41-955f-f4ce-e90c6403e67c	Product name	2	20210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1	Product name	2	20210729

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72789-550-10	Cefdinir	10 in 1 BOTTLE, PLASTIC	CAPSULE	10		18

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
72789-550-10	EA - Each	72789-550	72e46e66-c2d3-4b63-a0b3-8dbc3f3abd8d	1	2026-04-20

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 18 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefdinir	CEFDINIR	NuCare Pharmaceuticals, Inc.	5128dc70-f3cd-25c0-e063-6294a90aa52f	2026-05-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	c3892cd7-0e98-4ba3-a845-4aedf6c2a830	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	2da6eb80-63b0-4377-8d7b-865733ebbab1	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	PD-Rx Pharmaceuticals, Inc.	a5f028d5-ab33-491e-a385-56e79e165150	2026-02-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434 ndc (product): 72789-550
Cefdinir	CEFDINIR	REMEDYREPACK INC.	eb354221-c476-41cb-ad87-52423f81d698	2026-01-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	9ba5cb2d-6272-27de-e053-2995a90a58c8	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	PD-Rx Pharmaceuticals, Inc.	e296387e-eb20-4451-a184-f91748a4e9c7	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	PD-Rx Pharmaceuticals, Inc.	f4f62b64-5350-4b4e-b8f2-381f54a0cd10	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	PD-Rx Pharmaceuticals, Inc.	463084e5-908d-4bbc-b542-10b98211e28e	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	PD-Rx Pharmaceuticals, Inc.	3c2130f9-a0d8-4a4e-bcad-36379202b7bb	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Direct_Rx	f431ad55-24c8-e12a-e053-2a95a90aa043	2025-01-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	54b06071-f3cb-5627-e054-00144ff8d46c	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	8c3b89a9-cb3f-5960-e053-2995a90aaeee	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Rising Pharma Holdings, Inc.	a5594006-8e37-459e-8e85-7e2a83d7a57e	2024-02-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Aurobindo Pharma Limited	df26edb0-9bd6-449c-a187-0be0c9e2600c	2024-02-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	A-S Medication Solutions	7c25ae35-61f4-4aef-a8d9-8de77b02ab80	2023-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	Proficient Rx LP	506bcf51-3b7e-4fc0-b22e-a5b726471e3a	2023-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434
Cefdinir	CEFDINIR	BluePoint Laboratories	e342b7cf-f527-476e-8119-b1fd81c58b55	2023-03-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 065434 application number: ANDA065434

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CI0FAO63WC	CEFDINIR	91832-40-5	CEFDINIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
200346	cefdinir 300 MG Oral Capsule	PSN	a5f028d5-ab33-491e-a385-56e79e165150	18
200346	cefdinir 300 MG Oral Capsule	SCD	a5f028d5-ab33-491e-a385-56e79e165150	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
72789-550-10	72789055010	10 CAPSULE in 1 BOTTLE, PLASTIC (72789-550-10)	10 capsule	2026-02-24	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir Capsules, USP Rx only	PD-Rx Pharmaceuticals, Inc.	2026-02-24	HUMAN PRESCRIPTION DRUG LABEL	18